Jpmorgan Chase & CO Maravai Lifesciences Holdings, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,050,245 shares of MRVI stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,050,245
Previous 318,321 1172.38%
Holding current value
$22.7 Million
Previous $2.28 Million 1376.83%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$6.84 - $9.73 $25.5 Million - $36.3 Million
3,731,924 Added 1172.38%
4,050,245 $33.7 Million
Q3 2024

Nov 08, 2024
BUY
$6.84 - $9.73 $25.5 Million - $36.3 Million
3,731,924 Added 1172.38%
4,050,245 $33.7 Million
Q2 2024

Dec 26, 2024
SELL
$6.87 - $11.34 $25.6 Million - $42.3 Million
-3,731,924 Reduced 92.14%
318,321 $2.28 Million
Q2 2024

Aug 12, 2024
SELL
$6.87 - $11.34 $1.09 Million - $1.8 Million
-158,451 Reduced 33.23%
318,321 $2.28 Million
Q1 2024

Dec 26, 2024
SELL
$5.11 - $8.76 $18.3 Million - $31.3 Million
-3,573,473 Reduced 88.23%
476,772 $4.13 Million
Q1 2024

May 10, 2024
BUY
$5.11 - $8.76 $517,152 - $886,547
101,204 Added 26.95%
476,772 $4.13 Million
Q4 2023

Dec 26, 2024
SELL
$4.7 - $9.87 $17.3 Million - $36.3 Million
-3,674,677 Reduced 90.73%
375,568 $2.46 Million
Q4 2023

Feb 12, 2024
BUY
$4.7 - $9.87 $262,391 - $551,022
55,828 Added 17.46%
375,568 $2.46 Million
Q3 2023

Nov 14, 2023
SELL
$9.14 - $12.85 $74,061 - $104,123
-8,103 Reduced 2.47%
319,740 $3.2 Million
Q2 2023

Aug 11, 2023
SELL
$12.09 - $15.0 $43.1 Million - $53.4 Million
-3,562,634 Reduced 91.57%
327,843 $4.08 Million
Q1 2023

May 18, 2023
BUY
$12.99 - $16.48 $792,532 - $1.01 Million
61,011 Added 1.59%
3,890,477 $54.5 Million
Q1 2023

May 11, 2023
SELL
$12.99 - $16.48 $1.06 Million - $1.34 Million
-81,566 Reduced 2.09%
3,829,466 $53.7 Million
Q4 2022

Feb 13, 2023
BUY
$12.5 - $24.78 $4.08 Million - $8.08 Million
326,260 Added 9.1%
3,911,032 $56 Million
Q3 2022

Nov 14, 2022
BUY
$20.6 - $30.37 $1.12 Million - $1.65 Million
54,211 Added 1.54%
3,584,772 $91.5 Million
Q2 2022

Aug 11, 2022
BUY
$26.05 - $37.48 $3.54 Million - $5.1 Million
135,961 Added 4.01%
3,530,561 $100 Million
Q1 2022

May 11, 2022
SELL
$24.46 - $40.92 $2.85 Million - $4.77 Million
-116,607 Reduced 3.32%
3,394,600 $120 Million
Q4 2021

Feb 10, 2022
SELL
$35.0 - $45.94 $15.9 Million - $20.9 Million
-455,348 Reduced 11.48%
3,511,207 $147 Million
Q3 2021

Nov 12, 2021
BUY
$36.8 - $60.62 $146 Million - $240 Million
3,966,555 New
3,966,555 $195 Million

Others Institutions Holding MRVI

# of Institutions
234
Shares Held
140M
Call Options Held
223K
Put Options Held
19.4K
View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI Quotes by TradingView
  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email